Bortezomib for Injection recalled for lack of sterility assurance
Reliance Life Sciences Private Limited is recalling bortezomib for injection, 3.5 mg per single-dose vial, manufactured for Somerset Therapeutics, for lack of sterility assurance. The recall covers 11,400 vials distributed nationwide. No injuries have been reported.
From the FDA notice · Read the official notice ↗
What to do
- Set aside any vials from the affected lots and do not use them.
- Check the NDC (70069-0836-01) and the lot and expiry dates against lots RBIH0125A (Jan 31, 2028), RBIH0225A (Feb 29, 2028), RBIH0325A (Feb 29, 2028), and RBIH0525A (Mar 31, 2028).
- Contact Somerset Therapeutics or Reliance Life Sciences for next steps. The notice does not say how to get a refund or replacement.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
This recall covers 4 products — see all of them.
Details
- Units affected
- 11,400 vials
- Illnesses reported
- None reported
- Manufactured in
- Ttc Area Of Midc, R - 282 Dhirubhai Ambani Life Sciences Centre; Thane Belapur Road, Navi Mumbai, N/A, India
- Classification
- Class II
- Recall number
- D-0673-2026
In the FDA's words
- Description
- Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01 Lack of Sterility Assurance Lot, expiry: RBIH0125A Jan 31, 2028; RBIH0225A Feb 29, 2028; RBIH0325A Feb 29, 2028; RBIH0525A Mar 31, 2028 Distribution: Nationwide in the USA Affected quantity: 11,400 vials
- Hazard
- Lack of Sterility Assurance
4 products in this recall
Somerset Therapeutics cancer drug vials recalled for lack of sterility
Reliance Life Sciences is recalling four injectable cancer drugs made for Somerset Therapeutics: Pemetrexed for Injection 100 mg and 500 mg vials, Bortezomib for Injection 3.5 mg vials, and Azacitidine for Injection 100 mg vials. The recall covers about 36,000 vials nationwide because of a lack of sterility assurance. No injuries have been reported.
The agency lists each product separately. Check every one you might have.
- Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC.,…D-0671-2026 · 12,000 vials
- Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC.,…D-0672-2026 · 5,020 vials
- Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset… (this page)D-0673-2026 · 11,400 vials
- Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Intravenous Use, Rx only, Manufactured for: Somerset Therap…D-0674-2026 · 8,001 vials